ATE109773T1 - Acylierungsprodukte von 9,10- - Google Patents

Acylierungsprodukte von 9,10-

Info

Publication number
ATE109773T1
ATE109773T1 AT87115324T AT87115324T ATE109773T1 AT E109773 T1 ATE109773 T1 AT E109773T1 AT 87115324 T AT87115324 T AT 87115324T AT 87115324 T AT87115324 T AT 87115324T AT E109773 T1 ATE109773 T1 AT E109773T1
Authority
AT
Austria
Prior art keywords
acylation products
acylation
products
ylhydrazoles
anthracenedicarboxaldehyde
Prior art date
Application number
AT87115324T
Other languages
English (en)
Inventor
Keith Chadwick Murdock
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE109773T1 publication Critical patent/ATE109773T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/52Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
AT87115324T 1986-10-23 1987-10-20 Acylierungsprodukte von 9,10- ATE109773T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92222086A 1986-10-23 1986-10-23

Publications (1)

Publication Number Publication Date
ATE109773T1 true ATE109773T1 (de) 1994-08-15

Family

ID=25446718

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87115324T ATE109773T1 (de) 1986-10-23 1987-10-20 Acylierungsprodukte von 9,10-

Country Status (16)

Country Link
EP (1) EP0264901B1 (de)
JP (1) JPS63115868A (de)
KR (1) KR880005119A (de)
AT (1) ATE109773T1 (de)
AU (1) AU602537B2 (de)
CA (1) CA1321204C (de)
DE (1) DE3750358D1 (de)
DK (1) DK553587A (de)
FI (1) FI874653A (de)
HU (1) HU206087B (de)
IL (1) IL84213A (de)
NO (1) NO170331C (de)
NZ (1) NZ222250A (de)
PH (1) PH25711A (de)
PT (1) PT85982B (de)
ZA (1) ZA877951B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0338372A3 (de) * 1988-04-22 1991-10-09 American Cyanamid Company Solubilisierte Vorstufen von Medikamenten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996372A (en) * 1975-12-03 1976-12-07 Shell Oil Company Insecticidal 1-acyl-3-substituted-2-(nitro(phenylthio)-methylene)imidazolidines
GB2009171B (en) * 1977-11-28 1982-08-18 American Cyanamid Co Anthracene bis-carbonyl hydrazones and derivatives
US4258181A (en) * 1978-09-05 1981-03-24 American Cyanamid Company Substituted 9,10-anthracenebishydrazones
DE3133887A1 (de) * 1981-08-27 1983-03-10 Bayer Ag, 5090 Leverkusen 2-arylhydrazino-2-imidazoline, deren acylderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von endo- und ektoparasiten

Also Published As

Publication number Publication date
EP0264901A1 (de) 1988-04-27
AU8003387A (en) 1988-04-28
NO170331B (no) 1992-06-29
EP0264901B1 (de) 1994-08-10
HU206087B (en) 1992-08-28
CA1321204C (en) 1993-08-10
NZ222250A (en) 1990-04-26
HUT45505A (en) 1988-07-28
IL84213A (en) 1992-09-06
NO170331C (no) 1992-10-07
IL84213A0 (en) 1988-03-31
JPS63115868A (ja) 1988-05-20
NO874404L (no) 1988-04-25
FI874653A0 (fi) 1987-10-22
PT85982A (en) 1987-11-01
AU602537B2 (en) 1990-10-18
KR880005119A (ko) 1988-06-28
PH25711A (en) 1991-09-18
NO874404D0 (no) 1987-10-22
FI874653A (fi) 1988-04-24
DK553587A (da) 1988-04-24
ZA877951B (en) 1988-04-26
DK553587D0 (da) 1987-10-22
PT85982B (pt) 1990-08-31
DE3750358D1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
DK172089D0 (da) 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf
BR1100989A (pt) Composto e composição de matéria
FI890311A0 (fi) Kemiska foereningar.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
DK336688A (da) Nucleosider od fremgangsmaade til fremstilling deraf
ES2043609T3 (es) Composiciones de interleucina-2.
DE3776391D1 (de) Fluessige zubereitungen von 1,2-benzisothiazolin-3-on, ihre herstellung und verwendung.
HUT51295A (en) Process for producing peptidalcohol derivatives of anticoagulant activity
ATE109773T1 (de) Acylierungsprodukte von 9,10-
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
ES2027654T3 (es) Procedimiento para preparar azafosfolenos.
ATE66459T1 (de) Herstellungsverfahren von trifluormethylverbindungen.
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis
ATE69137T1 (de) Stabilisiertes gossyplure und verfahren zu dessen herstellung.